Buying guide
Evie Ring (and EvieMED) vs Pixel Watch in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
Key differences
- Pixel Watch has more capabilities independently verified as autonomous (1 vs 0).
- Evie Ring (and EvieMED) has more verified real-world deployments (1 vs 0).
| Attribute | No image on file | |
|---|---|---|
| Manufacturer | Movano Health | |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Autonomy | — | ✓ 1 verified autonomous |
| Availability | pausedpaused | shipping-nowshipping |
| Price | Not announced | $349-$399 (actual sale price) |
| Capability claims | — |
|
| Brain | — | — |
| Verified deployments | 1United States | 0 |
| Privacy practices | — | 11cloud-upload, data-deletion-control, data-sale, data-retention, location-tracking, third-party-sharing, biometric-storage, biometric-storage, data-sale, data-deletion-control, data-retention |
| Sources on file | 8 | 17 |
Editorial summaries
Evie Ring (and EvieMED)
Movano Health's Evie Ring is a women's-health-focused smart ring (menstrual-cycle tracking, sleep, energy, heart rate, SpO2, and mood and goal trends; general-wellness, not a diagnostic) and the lifecycle-state-paused archetype of DEPLOY's biometric ring sub-cohort. The verified-vs-claimed distinction is critical: Evie Ring sales are PAUSED, not discontinued. Following Movano Health's Corvex reverse merger (closed March 19, 2026), an AI-infrastructure pivot, and a 1-for-10 reverse split, the company paused Evie Ring sales while a divestiture of its EvieMED clinical line is pending. EvieMED (the B2B/clinical variant) is an FDA 510(k)-cleared pulse oximeter and heart-rate device (December 2, 2024) for clinical trials, remote patient monitoring, and payors and pharma. DEPLOY records the consumer Evie Ring at paused availability with no current retail price. Aggregators routinely flatten this as 'Movano discontinued the Evie Ring'; the accurate state is sales-paused amid a corporate pivot, with the EvieMED divestiture pending (an intention where not yet closed). Movano Health trades as NASDAQ: MOVE (CEO John Mastrototaro).
Pixel Watch
The Google Pixel Watch (current hardware the Pixel Watch 4, October 2025; the Pixel Watch 3 remains supported) is a biometric-primary smartwatch and the first-of-kind-cleared archetype of the cohort. Its sensors (multipath PPG heart rate, ECG via crown and caseback, SpO2, skin temperature, accelerometer) drive HRV, breathing rate, and resting heart rate, on Fitbit and Google Health algorithms (Google owns Fitbit). It is a hardware purchase (about $349 for the 41mm aluminum, $399 for the 45mm, plus about $100 for LTE), with an optional Google Health Premium subscription ($9.99/month) that gates the Sleep Profile and the Gemini AI coach. DEPLOY records commercial maturity. Its standout verified achievement is loss-of-pulse detection, which received an FDA De Novo authorization in February 2025, a first-of-kind clearance for cardiac-event detection on a consumer watch; the cleared indication is specific and should not be read as a general cardiac-diagnostic claim. Google's broader biometric strategy also spans Fitbit (Charge, Sense, Versa).
Common questions
- What is the difference between Evie Ring (and EvieMED) and Pixel Watch?
- Evie Ring (and EvieMED) and Pixel Watch are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
- Is Evie Ring (and EvieMED) or Pixel Watch more autonomous?
- Pixel Watch has more capabilities independently verified as autonomous on the DEPLOY registry than Evie Ring (and EvieMED). DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
- Which has more verified deployments, Evie Ring (and EvieMED) or Pixel Watch?
- Evie Ring (and EvieMED) has more verified deployments (1) on the DEPLOY registry than Pixel Watch (0). DEPLOY counts a deployment only when confirmed at a named site with a primary source.
Recent coverage
- Pixel Watch 5 leak shows off four different finishesPixel Watch · The Verge · 2026-07-14
- The whole Pixel line could get more expensive this yearPixel Watch · The Verge · 2026-07-08
- Movano Health secures FDA clearance for EvieMED RingEvie Ring (and EvieMED) · AgentRecon · 2026-06-15
- FDA exempts more wearable AI features from oversightEvie Ring (and EvieMED) · AgentRecon · 2026-04-15
Related comparisons
- Lingo vs Evie Ring (and EvieMED)
- Apple Watch vs Evie Ring (and EvieMED)
- Fitbit (Charge / Sense / Versa) vs Evie Ring (and EvieMED)
- Garmin (Venu / Fenix / Forerunner) vs Evie Ring (and EvieMED)
- Evie Ring (and EvieMED) vs Oura Ring 4
- Evie Ring (and EvieMED) vs RingConn (Gen 2 / Gen 3)
- Evie Ring (and EvieMED) vs Samsung Galaxy Ring
- Evie Ring (and EvieMED) vs Samsung Galaxy Watch (and Galaxy Ring)
- Evie Ring (and EvieMED) vs Stelo
- Evie Ring (and EvieMED) vs Ultrahuman Ring (Air / Pro)
- Evie Ring (and EvieMED) vs Whoop (5.0 / MG)
- Evie Ring (and EvieMED) vs Withings ScanWatch
For AI assistants
Use DEPLOY in Claude, Cursor, and other AI assistants
Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.
Machine-readable: this page as markdown.